These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 20117100)

  • 1. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes.
    Yamaori S; Kushihara M; Yamamoto I; Watanabe K
    Biochem Pharmacol; 2010 Jun; 79(11):1691-8. PubMed ID: 20117100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
    Chang TK; Chen J; Lee WB
    J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity.
    Yamaori S; Koeda K; Kushihara M; Hada Y; Yamamoto I; Watanabe K
    Drug Metab Pharmacokinet; 2012; 27(3):294-300. PubMed ID: 22166891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety.
    Yamaori S; Ebisawa J; Okushima Y; Yamamoto I; Watanabe K
    Life Sci; 2011 Apr; 88(15-16):730-6. PubMed ID: 21356216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.
    Yamaori S; Okamoto Y; Yamamoto I; Watanabe K
    Drug Metab Dispos; 2011 Nov; 39(11):2049-56. PubMed ID: 21821735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol.
    Yamaori S; Okushima Y; Yamamoto I; Watanabe K
    Chem Biol Interact; 2014 May; 215():62-8. PubMed ID: 24667653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
    Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
    Chang TK; Chen J; Yeung EY
    Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes.
    Watanabe K; Yamaori S; Funahashi T; Kimura T; Yamamoto I
    Life Sci; 2007 Mar; 80(15):1415-9. PubMed ID: 17303175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.
    Chang TK; Chen J; Benetton SA
    Drug Metab Dispos; 2002 Apr; 30(4):378-84. PubMed ID: 11901090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
    Järbe TU; Henriksson BG; Ohlin GC
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):68-72. PubMed ID: 921403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol induces expression of human cytochrome P450 1A1 that is possibly mediated through aryl hydrocarbon receptor signaling in HepG2 cells.
    Yamaori S; Kinugasa Y; Jiang R; Takeda S; Yamamoto I; Watanabe K
    Life Sci; 2015 Sep; 136():87-93. PubMed ID: 26187180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.
    Mikstacka R; Rimando AM; Dutkiewicz Z; Stefański T; Sobiak S
    Bioorg Med Chem; 2012 Sep; 20(17):5117-26. PubMed ID: 22863525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7H-dibenzo[c,g]carbazole metabolism by the mouse and human CYP1 family of enzymes.
    Shertzer HG; Genter MB; Talaska G; Curran CP; Nebert DW; Dalton TP
    Carcinogenesis; 2007 Jun; 28(6):1371-8. PubMed ID: 17166882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety.
    Yamaori S; Okushima Y; Masuda K; Kushihara M; Katsu T; Narimatsu S; Yamamoto I; Watanabe K
    Biol Pharm Bull; 2013; 36(7):1197-203. PubMed ID: 23811569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha.
    Sparfel L; Van Grevenynghe J; Le Vee M; Aninat C; Fardel O
    Carcinogenesis; 2006 Mar; 27(3):656-63. PubMed ID: 16258175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
    Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
    Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.